You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in South Africa

Jul 2011

Price: $2,400

About this Report

About this Report

Delivery method: instant download
Report format: PDF doc_pdf.png (download a sample)
Market statistics: Excel workbook doc_excel_table.png (download a sample)

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in South Africa with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in South Africa, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in South Africa for free:

The Consumer Health in South Africa market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in South Africa?
  • What are the major brands in South Africa?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Market growth slow as the country gradually recovers from the recession

The consumer health care sector experienced a slowdown in the rate of growth as the country slowly recovered from the recession that hit the country in 2009. A lot of people were watching their spending as they had limited income at their disposal resulting in reduced volume sales of most businesses. The main contributing factor was the announcement by the sole power utility company, Eskom, that the electricity tariffs will be increased annually over the next three years, effective from June 2010. Most businesses became reluctant to hire more people and some were even retrenching in a bid to reduce their operational costs in the long run. This had a negative impact in the market as a whole as consumers now have limited spending power due to the increased rate of inflation.

The South African rand continues to strengthen against the dollar

The South African rand continuously strengthened against the US dollar in 2010 sparking fears of high operational costs for foreign pharmaceutical companies doing business in South Africa. This may come as good news for local companies competing with these foreign companies but the rate of foreign direct investment may slow down, as most existing international companies will question the viability of doing business in the country.

Pricing and positioning key to success in consumer health

With the ever increasing costs of consulting medical practitioners, consumers are now resorting to self medication to minimise spending. Retailers now face the challenge of luring consumers to their stores, and one of the key means of achieving this is to keep prices low and to position products correctly. Aggressive and consistent marketing of products in South Africa has become a key to the success for most businesses, as this ensures product awareness is improved amongst consumers. Television advertising still remains one of the most effective marketing tools, although most retailers and brand owners keep this to a minimum due to the high costs.

Choice of distribution channels now a key determinant to product success

Over the post-independence period from 1994, pharmacies have been the key point of access to self medication products. As such, brand owners have been forced to establish good relations with pharmacies to ensure that their products quickly get into the market. This strategy has proven to be effective, as witnessed by Adcock Ingram, Aspen and Vital Health Foods, all of whose products are distributed via pharmacies all over the country. However, grocery channels are also proving to be an efficient distribution channel, as has been seen over the last three years of the review period. Some retailers have even resorted to establishing in-store pharmacies, including Spar, which launched a branded in-store pharmacy in Kwa Zulu Natal in July 2010.

The market is expected to steadily grow while the cost of living rises

The market is expected to grow slowly due to an anticipated high cost of living and expected job losses, as inflation is expected to be fuelled by electricity tariff hikes over the next three years. As such, analysts are forecasting that jobs will be lost as companies try to reduce the cost of operating their businesses and at the same time pass the cost onto consumers with price increases. The result will be less disposable income within the market and low market growth.

Table of Contents

Table of Contents

Consumer Health in South Africa - Industry Overview

EXECUTIVE SUMMARY

Market growth slow as the country gradually recovers from the recession

The South African rand continues to strengthen against the dollar

Pricing and positioning key to success in consumer health

Choice of distribution channels now a key determinant to product success

The market is expected to steadily grow while the cost of living rises

KEY TRENDS AND DEVELOPMENTS

Stricter laws and anti-smoking campaigns drive sales of cessation aids

Consumer health care volume sales rise as more in-store pharmacies open

Over-the-counter sales decrease as people utilise free public medication

Social sites gradually become a powerful marketing tool for health products

Local businesses indirectly exposed to imported competition

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 2 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2005-2010
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 5 Consumer Health Company Shares by Value 2006-2010
  • Table 6 Consumer Health Brand Shares by Value 2007-2010
  • Table 7 Penetration of Private Label by Category 2005-2010
  • Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 10 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventative Medicine

Switches

  • Summary 1 OTC Healthcare Switches 2008-2010

DEFINITIONS

Sector and Subsector Definitions

  • Summary 2 Research Sources

Consumer Health in South Africa - Company Profiles

Adcock Ingram Ltd in Consumer Health (South Africa)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 5 Adcock Ingram Ltd: Competitive Position 2010

Aspen Pharmacare (Pty) Ltd in Consumer Health (South Africa)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Aspen Pharmacare Pty Ltd: Competitive Position 2010

Bioscience Brands Ltd in Consumer Health (South Africa)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 10 Bioscience Brands Pty Ltd: Competitive Position 2010

Cipla-Medpro (Pty) Ltd in Consumer Health (South Africa)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

Dischem (Pty) Ltd in Consumer Health (South Africa)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

COMPETITIVE POSITIONING

Novartis South Africa (Pty) Ltd in Consumer Health (South Africa)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

COMPETITIVE POSITIONING

  • Summary 15 Novartis South Africa Pty Ltd: Competitive Position 2010

Vital Health Foods (Pty) Ltd in Consumer Health (South Africa)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

COMPETITIVE POSITIONING

  • Summary 17 Vital Health Foods (Pty) Ltd: Competitive Position 2010

Adult Mouth Care in South Africa - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care grew by 7% during 2010. The growth did not shift upwards, due to the economic slowdown that impacted the country at the beginning of the year.

SWITCHES

CATEGORY DATA

  • Table 12 Sales of Adult Mouth Care: Value 2005-2010
  • Table 13 Sales of Adult Mouth Care: % Value Growth 2005-2010
  • Table 14 Adult Mouth Care Company Shares by Value 2006-2010
  • Table 15 Adult Mouth Care Brand Shares by Value 2007-2010
  • Table 16 Forecast Sales of Adult Mouth Care: Value 2010-2015
  • Table 17 Forecast Sales of Adult Mouth Care: % Value Growth 2010-2015

Analgesics in South Africa - Category Analysis

HEADLINES

TRENDS

  • Consumers in South Africa became extremely price-conscious over the last two years of the review period in the context of economic slowdown and shrinking disposable income. As a result, there was a shift towards cheaper options for products, including analgesics. Moreover, an increasing number of poor South Africans are now visiting free clinics to get their analgesics, instead of buying them over-the-counter. This resulted in a fall in sales of over-the-counter medication.

SWITCHES

COMPETITIVE LANDSCAPE

  • Adcock Ingram continues to lead in analgesics with a share of 35% in 2010.It is followed by GlaxoSmithKline with 14%. The popular brands of these companies have been available on the market for some time and have become household names. Supported by extensive marketing, the Panada and Grand-Pa brands are expected to remain dominant in the South African market.

PROSPECTS

  • This sector is expected to steadily grow over the forecast period as the need for self-medication continues to grow amongst South Africans. High medical costs associated with visiting medical practitioners are expected to force consumers to make use of self-medication. However, there is a fear that growth in the analgesics sector may be slower than expected if more South Africans continue to make use of the free medication available through public health institutions.

CATEGORY DATA

  • Table 18 Sales of Analgesics by Category: Value 2005-2010
  • Table 19 Sales of Analgesics by Category: % Value Growth 2005-2010
  • Table 20 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2005-2010
  • Table 21 Analgesics Company Shares by Value 2006-2010
  • Table 22 Analgesics Brand Shares by Value 2007-2010
  • Table 23 Forecast Sales of Analgesics by Category: Value 2010-2015
  • Table 24 Forecast Sales of Analgesics by Category: % Value Growth 2010-2015

Calming and Sleeping in South Africa - Category Analysis

HEADLINES

TRENDS

  • Value sales of calming and sleeping products grow by 6% to reach R18 million in 2010, which is slightly higher than the CAGR for the review period. The growth in the number of people working irregular hours is also contributing towards the number of people suffering from sleeping disorders. For instance, over the past few years, quite a number of European and American companies have been outsourcing labour from South Africa in the form of call centre services, as well as online assistance services. Due to time zone differentials, some South African citizens have found themselves working extended hours, resulting in sleeping disorders. This has given rise to demand for sleeping disorder remedies and sector growth.

SWITCHES

CATEGORY DATA

  • Table 25 Sales of Calming and Sleeping: Value 2005-2010
  • Table 26 Sales of Calming and Sleeping: % Value Growth 2005-2010
  • Table 27 Calming and Sleeping Company Shares by Value 2006-2010
  • Table 28 Calming and Sleeping Brand Shares by Value 2007-2010
  • Table 29 Forecast Sales of Calming and Sleeping: Value 2010-2015
  • Table 30 Forecast Sales of Calming and Sleeping: % Value Growth 2010-2015

Cough, Cold and Allergy (Hay Fever) Remedies in South Africa - Category Analysis

HEADLINES

TRENDS

  • The changing weather and varying climates in South Africa continue to expose its citizens to various forms of colds and flu. This is particularly common in Cape Town where the weather can quickly change from very warm conditions to cold and wet within one season. This causes many f people to suffer from colds and flu as well as hay fever. The overall effect has been an increase in the volume and value sales of cough and cold medication throughout the whole year.

SWITCHES

COMPETITIVE LANDSCAPE

  • Adcock continues to lead with a 17% share in 2010 thanks to its broad product portfolio that ensures there is an Adcock product in almost every category of cough, cold and allergy remedies. The Adcock products are also competitively priced to ensure that business is not lost to other competitors, such as GlaxoSmithKline, which currently holds second position, with a share of 10%

PROSPECTS

  • The cough, cold and allergy remedy sector is anticipated to steadily grow as more South Africans are now resorting to self-medication in place of visiting doctors due their high costs. However, the growth may not be as expected if the majority of consumers start making use of the free publicly available medication in public health institutions. This would result in a fall in sales of over-the-counter medication.

CATEGORY DATA

  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 32 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 33 Sales of Decongestants by Category: Value 2005-2010
  • Table 34 Sales of Decongestants by Category: % Value Growth 2005-2010
  • Table 35 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2005-2010
  • Table 36 Sales of Child-specific Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2005-2010
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2006-2010
  • Table 38 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2007-2010
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2010-2015
  • Table 40 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2010-2015

Digestive Remedies in South Africa - Category Analysis

HEADLINES

TRENDS

  • The previous year’s growth was slightly exceeded in 2010 to reach 10%, which was quite significant considering the sector is relatively mature. Competition was intense but major brands still managed to post notable growth in 2010.

SWITCHES

COMPETITIVE LANDSCAPE

  • GlaxoSmithKline SA Ltd leads with 19% followed by Adcock on 18%. Reckitt and Benckiser was in third place, with a share of 14%.

PROSPECTS

  • This sector is expected to have stable growth over the forecast period. This is because digestive system related illnesses continue to be on the rise and are not expected to slow down anytime soon.

CATEGORY DATA

  • Table 41 Sales of Digestive Remedies by Category: Value 2005-2010
  • Table 42 Sales of Digestive Remedies by Category: % Value Growth 2005-2010
  • Table 43 Digestive Remedies Company Shares by Value 2006-2010
  • Table 44 Digestive Remedies Brand Shares by Value 2007-2010
  • Table 45 Forecast Sales of Digestive Remedies by Category: Value 2010-2015
  • Table 46 Forecast Sales of Digestive Remedies by Category: % Value Growth 2010-2015

Ear Care in South Africa - Category Analysis

HEADLINES

TRENDS

  • Ear care sales in South Africa increased by 7% to reach sales R29 million in 2010. This performance is in line with the review period. Ear problems are not very common, therefore when they happen, patients tend to prefer to consult medical practitioners to find a remedy. This limits over-the-counter sales.

SWITCHES

CATEGORY DATA

  • Table 47 Sales of Ear Care: Value 2005-2010
  • Table 48 Sales of Ear Care: % Value Growth 2005-2010
  • Table 49 Ear Care Company Shares by Value 2006-2010
  • Table 50 Ear Care Brand Shares by Value 2007-2010
  • Table 51 Forecast Sales of Ear Care: Value 2010-2015
  • Table 52 Forecast Sales of Ear Care: % Value Growth 2010-2015

Emergency Contraception in South Africa - Category Analysis

HEADLINES

TRENDS

  • Emergency contraception grew by 13% in 2010 to reach R237 million. This was due to the economic slowdown, which limited the amount of income available for disposal and restricted an increase in the sales of emergency contraception. Emergency contraption pills are a relatively expensive over-the-counter product which discourages many consumers.

CATEGORY DATA

  • Table 53 Sales of Emergency Contraception: Value 2005-2010
  • Table 54 Sales of Emergency Contraception: % Value Growth 2005-2010
  • Table 55 Emergency Contraception Company Shares by Value 2006-2010
  • Table 56 Emergency Contraception Brand Shares by Value 2007-2010
  • Table 57 Forecast Sales of Emergency Contraception: Value 2010-2015
  • Table 58 Forecast Sales of Emergency Contraception: % Value Growth 2010-2015

Eye Care in South Africa - Category Analysis

HEADLINES

TRENDS

  • Current value sales of eye care grew by 7% in 2010 to reach R105 million, which was a slight growth compared with the previous year. This growth was significant, considering the economic conditions that prevailed during 2009-2010. Consumer spending shrank in 2010, but this did not reduce the volume sales in any way and, hence, the growth rate was maintained.

SWITCHES

COMPETITIVE LANDSCAPE

  • Adcock Ingram leads the sector with a 33% value share in 2010. It continues to dominate because its brands have been around for quite some time and have become household brands, of which consumers and medical practitioners are fully aware. This has been a great help in boosting the volume sales of Adcock’s brands, especially Spersallerg in allergy eye care.

CATEGORY DATA

  • Table 59 Sales of Eye Care by Category: Value 2005-2010
  • Table 60 Sales of Eye Care by Category: % Value Growth 2005-2010
  • Table 61 Standard Eye Care by Type: % Value Breakdown 2007-2010
  • Table 62 Eye Care Company Shares by Value 2006-2010
  • Table 63 Eye Care Brand Shares by Value 2007-2010
  • Table 64 Forecast Sales of Eye Care by Category: Value 2010-2015
  • Table 65 Forecast Sales of Eye Care by Category: % Value Growth 2010-2015

Herbal/Traditional Products in South Africa - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional products increased by 9% in current terms in 2010, with sales reaching R383 million. This growth was in line with that of the previous year. A lack of strong marketing campaigns and new product innovations led to this trend. Approximately 50% of sales were attributed to herbal dietary supplements.

COMPETITIVE LANDSCAPE

  • Cadbury led the sector with an 18% value share in 2010. Pharma Natura followed in second place with an 11% share and R40 million sales.

PROSPECTS

  • Herbal/traditional products are expected to experience increased awareness and acceptance among consumers over the forecast period in South Africa. Consumers perceive this product to be healthier and to have fewer side-effects than standard products and will use it in a drive to be more health conscious. The recent up-scheduling of many products will lead to the introduction of herbal alternatives, as manufacturers will attempt to regain share of the sector. Stricter legislation on the claims and quality of herbal/traditional products has not currently been implemented in South Africa but, once it is finalised, consumers will have increased trust in the brands that they find on the shelves.

CATEGORY DATA

  • Table 66 Sales of Herbal/Traditional Products: Value 2005-2010
  • Table 67 Sales of Herbal/Traditional Products: % Value Growth 2005-2010
  • Table 68 Herbal/Traditional Products Company Shares 2006-2010
  • Table 69 Herbal/Traditional Products Brand Shares 2007-2010
  • Table 70 Forecast Sales of Herbal/Traditional Products: Value 2010-2015
  • Table 71 Forecast Sales of Herbal/Traditional Products: % Value Growth 2010-2015

Medicated Skin Care in South Africa - Category Analysis

HEADLINES

TRENDS

  • Unpredictable weather patterns continued to expose quite a number of people to varying skin conditions during 2010. As a result, there has been growth in demand for treatments for skin conditions. Equally, some concerned individuals have also resorted to preventive measures, particularly in coastal areas such as Cape Town and Durban, where there are common rashes that come from sea insect bites, as well as reactions to varying weather patterns.

SWITCHES

COMPETITIVE LANDSCAPE

  • Reckitt Benckiser continued to lead the sector with a 25% value share as the company possesses a broad product portfolio. The company has also established effective distribution channels, which allow its products to be supplied to consumers using almost every available retail channel or selling point for skin care products.

PROSPECTS

  • Hair loss treatments and other medicated skin care products are expected to perform well over the forecast period due to the high incidence of HIV patients in the country. HIV related illnesses also involve hair loss as well as some skin conditions during the initial stages of HIV.

CATEGORY DATA

  • Table 72 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 73 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 74 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 75 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 76 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 77 Acne Treatments Brand Shares by Value 2007-2010
  • Table 78 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 79 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 80 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

NRT Smoking Cessation Aids in South Africa - Category Analysis

HEADLINES

TRENDS

  • The government of South Africa recently introduced stricter smoking laws in a bid to reduce the incidence of smoking. Fines for smoking in prohibited public places were increased to as much as R500 per person and the business fines were also raised to R50,000 for any violation to these smoking laws.

SWITCHES

COMPETITIVE LANDSCAPE

  • Nicorette from Pfizer is the leading brand within this sector, with an 86% value share, down almost four percentage points on the previous year. The main reason why the share is dropping is because there has been an increase in the number of new entrants within this sector, although it was at a minimal level.

PROSPECTS

  • The new smoking legislation is expected to reduce the number of smokers over the forecast period and in the process it is also expected to boost the volume sales of smoking cessation aids, as more people are expected to resort to quitting in place of suffering from cravings when they feel like smoking in prohibited areas.

CATEGORY INDICATORS

  • Table 81 Number of Smokers by Gender 2005-2010

CATEGORY DATA

  • Table 82 Sales of NRT Smoking Cessation Aids by Category: Value 2005-2010
  • Table 83 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2005-2010
  • Table 84 NRT Gum Flavours: % Value Breakdown 2006-2010
  • Table 85 NRT Smoking Cessation Aids Company Shares by Value 2006-2010
  • Table 86 NRT Smoking Cessation Aids Brand Shares by Value 2007-2010
  • Table 87 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2010-2015
  • Table 88 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2010-2015

Sports Nutrition in South Africa - Category Analysis

HEADLINES

TRENDS

  • Sports nutrition grew by 10% in 2010 to reach R335 million. The growth in 2010 was influenced by an increase in the number of people engaged in body building through public gyms and personal work outs at home. The results of such exercise can be boosted via the aid of sports food supplements, such as creatine, which helps in delaying the onset of muscle fatigue when an individual is working out.

COMPETITIVE LANDSCAPE

  • Ultimate Sports Nutrition (USN) led the market in 2010 with a 71% value share. This was stimulated by the fact that the brand is extensively marketed globally making it easy for anyone to identify them in times of need. This market dominance was also supported by periodic promotions held around busy shopping malls, where consumers are given trial products and also educated on the effectiveness of USN brands. In second place was Bioscience Brands with a 6% share followed by Abbott Laboratories in third place on 3%.

PROSPECTS

  • Steady growth is expected over the forecast period due to the anticipated rise in the number of people joining gyms for fitness training over the forecast period. The increase in the number of sign ups is expected to encourage trainees to buy sporting food supplements to improve their work out plans and results.

CATEGORY DATA

  • Summary 18 Sports Nutrition, category rankings 2010
  • Table 89 Sales of Sports Nutrition: Value 2005-2010
  • Table 90 Sales of Sports Nutrition: % Value Growth 2005-2010
  • Table 91 Sports Nutrition By Format: % Value Breakdown 2007-2010
  • Table 92 Sports Nutrition Company Shares 2006-2010
  • Table 93 Sports Nutrition Brand Shares 2007-2010
  • Table 94 Forecast Sales of Sports Nutrition: Value 2010-2015
  • Table 95 Forecast Sales of Sports Nutrition: % Value Growth 2010-2015

Vitamins and Dietary Supplements in South Africa - Category Analysis

HEADLINES

TRENDS

  • There was a general slowdown in sales across all aspects of the economy in 2010, including the vitamins and dietary supplements sector. The country was on the recovery path from the recession that hit particularly hard in the latter months of 2009.This had a negative impact on the overall sector, as consumers monitored their spending and avoided buying items that were deemed to be secondary to their needs. In South Africa, dietary supplements are perceived as luxury items and very few people are eager to purchase them. This was reflected in the lower rate of growth for probiotic supplements to 25%, compared to the previous year when it was 27%.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Vital Health Foods led retail value sales in 2010 with a 14% share of vitamins and dietary supplements. This South African company focused on high-quality vitamins and dietary supplements, introducing new products specifically aimed at certain ailments to increase market share. Vital Arthrit Ease and Vital Cranberry Complex focused on preventing and alleviating arthritis and urinary tract infection, respectively. In 2010, Vital also launched another new product - Vital Liver Rescue - which helps the liver in the detoxification process. New product launches, alongside well-established brands such as Vital and Natrodale resulted in Vital Health Foods taking a leading role in retail value share. Bayer followed closely with 12% in 2010 thanks to its well-established brands that included Cal-C-Vita and Berocca.

PROSPECTS

  • The sector value growth over the forecast period is expected to be slower than previous years as the vitamins and supplements sector is now saturated in terms of brand availability and more new products are still being launched. This is expected to force serious price competition, which is likely to reduce the expected value growth rate with the products being relatively lower priced than they should be.

CATEGORY DATA

  • Summary 19 Dietary Supplements: Brand Ranking by Positioning 2010
  • Table 96 Sales of Vitamins and Dietary Supplements by Category: Value 2005-2010
  • Table 97 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2005-2010
  • Table 98 Dietary Supplements by Positioning 2005-2010
  • Table 99 Vitamins and Dietary Supplements Company Shares by Value 2006-2010
  • Table 100 Vitamins and Dietary Supplements Brand Shares by Value 2007-2010
  • Table 101 Vitamins Brand Shares by Value 2007-2010
  • Table 102 Dietary Supplements Brand Shares by Value 2007-2010
  • Table 103 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2010-2015
  • Table 104 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2010-2015

Weight Management in South Africa - Category Analysis

HEADLINES

TRENDS

  • Weight management grew by 11% in 2010 to reach R535 million. The growth was constant when compared with the previous year where a similar growth was recorded. This was due to the general slowdown in the economy at the beginning of the year, which discouraged consumers from continuing their usage of such products, as they are deemed to be luxury products.

COMPETITIVE LANDSCAPE

  • Herbalife led with a 25% share of value sales in 2010, which was a drop from the previous year at 28%. In second place, More-to-Life was present with its GI Lean brand. The value share for the leader Herbalife fell because competition began intensifying and consumers began trying out cheaper alternatives when the economic slowdown took a toll at the beginning of 2010.

PROSPECTS

  • Growth over the forecast period is expected to be steady as more people will become aware of the possible options to manage their weight, apart from avoiding eating specific food items. Many South Africans now seek to improve their lifestyles as their incomes increase and managing weight is expected to be one of their priorities. This will eventually contribute towards the growth of the weight management sector.

CATEGORY DATA

  • Table 105 Sales of Weight Management: Value 2005-2010
  • Table 106 Sales of Weight Management: % Value Growth 2005-2010
  • Table 107 Weight Management Company Shares 2006-2010
  • Table 108 Weight Management Brand Shares 2007-2010
  • Table 109 Forecast Sales of Weight Management: Value 2010-2015
  • Table 110 Forecast Sales of Weight Management: % Value Growth 2010-2015

Wound Care in South Africa - Category Analysis

HEADLINES

TRENDS

  • Wound care grew by 8% in value in 2010 to reach sales of R105 million. There was growing demand for first aid kits, prompted by growing product awareness during the year. First aid kits are also increasingly available for the general public, mainly through pharmacies and health shops in South Africa.

CATEGORY DATA

  • Table 111 Sales of Wound Care by Category: Value 2005-2010
  • Table 112 Sales of Wound Care by Category: % Value Growth 2005-2010
  • Table 113 Wound Care Company Shares by Value 2006-2010
  • Table 114 Wound Care Brand Shares by Value 2007-2010
  • Table 115 Forecast Sales of Wound Care by Category: Value 2010-2015
  • Table 116 Forecast Sales of Wound Care by Category: % Value Growth 2010-2015

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Child-Specific Analgesics
            • Child-Specific Acetaminophen
            • Child-Specific Aspirin
            • Child-Specific Combination Products - Analgesics
            • Child-Specific Diclofenac
            • Child-Specific Dipyrone
            • Child-Specific Ibuprofen
            • Child-Specific Ketoprofen
            • Child-Specific Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Child-Specific Cough, Cold and Allergy Remedies
          • Child-Specific Allergy Remedies
          • Child-Specific Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Child-Specific Digestive Remedies
          • Child-Specific Diarrhoeal Remedies
          • Child-Specific Indigestion and Heartburn Remedies
          • Child-Specific Laxatives
          • Child-Specific Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Acne Treatments
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Child-Specific Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
    • Vitamins and Dietary Supplements
      • Child-Specific Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
            • Grape Seed
            • Isoflavones
            • Microalgae
            • Other Other Herbal/Traditional Dietary Supplements
        • Non-Herbal Dietary Supplements
          • Calcium Supplements
          • Co-Enzyme Q10
          • Combination Non-Herbal Dietary Supplements
          • Eye Health Supplements
          • Fish Oils
            • Cod Liver Oil
            • Other Fish Oils
          • Glucosamine
          • Mineral Supplements
          • Omega-3-6-9 (Fish and Non-Fish)
          • Probiotic Supplements
          • Protein Powder
          • Royal Jelly
          • Sam-E
          • Other Non-Herbal Dietary Supplements
            • Lecithin
            • Other Other Non-Herbal Dietary Supplements
      • Tonics and Bottled Nutritive Drinks
      • Vitamins
        • Multivitamins
        • Single Vitamins
          • Vitamin A
          • Vitamin B
          • Vitamin C
          • Vitamin D
          • Vitamin E
          • Other Single Vitamins
    • Weight Management
      • Meal Replacement Slimming
      • OTC Obesity
      • Slimming Teas
      • Weight Loss Supplements
      • Other Slimming Products
    • Herbal/Traditional Products
      • Herbal/Traditional Analgesics
      • Herbal/Traditional Calming and Sleeping Products
      • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
      • Herbal/Traditional Digestive Remedies
      • Herbal/Traditional Medicated Skin Care
      • Herbal/Traditional Medicinal Teas
      • Herbal/Traditional Smoking Cessation Aids
      • Herbal/Traditional Child-Specific Dietary Supplements
      • Herbal/Traditional Dietary Supplements
      • Herbal/Traditional Tonics and Bottled Nutritive Drinks
    • Allergy Care
      • Allergy Eye Care
      • Antihistamines/Allergy Remedies (Systemic)
      • Child-Specific Allergy Remedies
      • Topical Allergy Remedies/Antihistamines
    • Child-Specific Consumer Health
      • Child-Specific Analgesics
        • Child-Specific Acetaminophen
        • Child-Specific Aspirin
        • Child-Specific Combination Products - Analgesics
        • Child-Specific Diclofenac
        • Child-Specific Dipyrone
        • Child-Specific Ibuprofen
        • Child-Specific Ketoprofen
        • Child-Specific Naproxen
      • Child-Specific Cough, Cold and Allergy Remedies
        • Child-Specific Allergy Remedies
        • Child-Specific Cough/Cold Remedies
      • Child-Specific Digestive Remedies
        • Child-Specific Diarrhoeal Remedies
        • Child-Specific Indigestion and Heartburn Remedies
        • Child-Specific Laxatives
        • Child-Specific Motion Sickness Remedies
      • Child-Specific Medicated Skin Care
      • Nappy (Diaper) Rash Treatments
      • Child-Specific Vitamins and Dietary Supplements

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

RELATED

Country Report

Consumer Lifestyle

Country Report

Future Demographic